homocysteine has been researched along with pirfenidone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chen, L; Li, L; Li, X; Ma, K; Ouyang, Y; Si, J; Wang, L; Zhang, L | 1 |
| Deng, Y; Kong, J | 1 |
1 trial(s) available for homocysteine and pirfenidone
| Article | Year |
|---|---|
Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia.
Topics: Animals; Antioxidants; Glutathione Peroxidase; Homocysteine; Hyperhomocysteinemia; Hyperplasia; Lipids; Malondialdehyde; Methionine; Oxidants; Pyridones; Rabbits; Reactive Oxygen Species; Superoxide Dismutase; Tunica Intima | 2022 |
1 other study(ies) available for homocysteine and pirfenidone
| Article | Year |
|---|---|
Pirfenidone attenuates homocysteine‑induced apoptosis by regulating the connexin 43 pathway in H9C2 cells.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Connexin 43; Homocysteine; Myocytes, Cardiac; Pyridones; Rats; Signal Transduction | 2020 |